Press Releases


Media Contact:
Stephen Majors
Head of Global Communications
smajors@alliancerm.org


Media Contact:
Stephen Majors
Head of Global Communications
smajors@alliancerm.org

New Analysis by Tufts’ NEWDIGS Shows that Durable Cell and Gene Therapies Have Substantially Higher Clinical Success Rates than Other Treatments

October 11, 2023

Carlsbad, CA

New analysis shows that durable cell and gene therapies have clinical success rates between two and three times higher than other types of treatments.


The Alliance for Regenerative Medicine Announces Election of 2024 Board of Directors

October 10, 2023

Carlsbad, CA

The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines, today announced the election of its 2024 Board of Directors.


Alliance for Regenerative Medicine Promotes Michael Lehmicke to Senior Vice President, Science & Industry Affairs

July 19, 2023

Washington, DC

The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and genetic medicines sector, announced the promotion of Michael Lehmicke to Senior Vice President, Science & Industry Affairs, effective immediately.


Proposed joint clinical assessment methodology would have rejected nearly 90% of the ATMPs currently authorized in the EU

June 20, 2023

BRUSSELS

Without changes recognizing the unique characteristics of ATMPs, the EU’s new Joint Clinical Assessment will fail to deliver the next generation of transformative therapies to rare disease patients, according to the Alliance for Regenerative Medicine, EveryLife Foundation for Rare Diseases, and Rare Diseases International.